Comorbidity After Gastric Bypass

Uppsala University

Status: Enrolling

Conditions: Severe Obesity

Treatments: Procedure: Gastric bypass

Study type: Observational

Funder types: Other

Identifiers

NCT02710786

Comorb

Details and patient eligibility

About

To evaluate effect on comorbid disease and weight loss in the long-term (>five years) after Roux-en-Y gastric bypass (RYGB) surgery for severe obesity.

Full description

Individuals with severe obesity frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss in the long-term (10 years) after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.

Enrollment: 25,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Registered individuals in Scandinavian Obesity Surgery Registry (SOReg) having had gastric bypass

Exclusion criteria

• All other operations

Trial design

25,000 participants in 1 patient group

Gastric bypass

Description:

Patients undergoing gastric bypass

Treatment:

Procedure: Gastric bypass